Scientific Advisory Board
Focusing on antiobiotics
The field of antibiotics is one of the major focuses for PharmaCytics.
In the field of fighting resistance, patient compliance and improving side effects there is a lot to gain.
NDCt can accomplish that, e.g. by turning parenteral antibiotics into an oral.
Part of PharmaCytics’ strategy is to ask opinion leaders in the field for advice e.g. on the choice of compounds – benefitting the patient the most.
For antibiotics we had a kick of meeting on these topics and we are happy to te tell that thought leaders mentioned below are prepared to share their vision on these topic with us.
Jaap Wieling, PhD
Jaap Wieling, PhD
Dr. David P. Nicolau
Director of the Center for Anti-Infective Research and Development and Coordinator for Research in the Department of Medicine, Division of Infectious Diseases and Pharmacy at Hartford Hospital in Connecticut
After receiving his PharmD from the Medical University of South Carolina in Charleston, Dr. Nicolau completed two ASHP residencies, a residency in hospital pharmacy at Boston Medical Center in Boston, Massachusetts, and a residency in adult internal medicine at Medical University Hospital in Charleston, South Carolina. Subsequently, he completed a Clinical Pharmacy Fellowship in infectious diseases pharmacotherapy at Hartford Hospital in Hartford, Connecticut.
Dr. Nicolau’s investigations of antibiotic activity against infection and his examinations of alternative methods in antimicrobial therapy are reported in over 380 published articles and 256 abstracts. He serves on the editorial board of several peer-reviewed journals, including Diagnostic Microbiology and Infectious Diseases, Surgical Infections, Infectious Diseases in Clinical Practice, and Expert Opinion in Pharmacotherapy.
Dr. Nicolau’s research interests include clinical pharmacokinetics, pharmacodynamics, and the development of antimicrobial utilization methodologies focusing on animal models of infection, healthy volunteer studies, and clinical studies as tools for success. He is a member of the American Society of Health-System Pharmacists (ASHP), the ASHP Infectious Diseases Special Practice Group, and the Society of Infectious Diseases Pharmacists.
Dr. David P. Nicolau
Director of the Center for Anti-Infective Research and Development and Coordinator for Research in the Department of Medicine, Division of Infectious Diseases and Pharmacy at Hartford Hospital in Connecticut
After receiving his PharmD from the Medical University of South Carolina in Charleston, Dr. Nicolau completed two ASHP residencies, a residency in hospital pharmacy at Boston Medical Center in Boston, Massachusetts, and a residency in adult internal medicine at Medical University Hospital in Charleston, South Carolina. Subsequently, he completed a Clinical Pharmacy Fellowship in infectious diseases pharmacotherapy at Hartford Hospital in Hartford, Connecticut.
Dr. Nicolau’s investigations of antibiotic activity against infection and his examinations of alternative methods in antimicrobial therapy are reported in over 380 published articles and 256 abstracts. He serves on the editorial board of several peer-reviewed journals, including Diagnostic Microbiology and Infectious Diseases, Surgical Infections, Infectious Diseases in Clinical Practice, and Expert Opinion in Pharmacotherapy.
Dr. Nicolau’s research interests include clinical pharmacokinetics, pharmacodynamics, and the development of antimicrobial utilization methodologies focusing on animal models of infection, healthy volunteer studies, and clinical studies as tools for success. He is a member of the American Society of Health-System Pharmacists (ASHP), the ASHP Infectious Diseases Special Practice Group, and the Society of Infectious Diseases Pharmacists.
David Livermore
Professor of Medical Microbiology, University of East Anglia
David Livermore gained his BSc in 1978 and PhD in 1983.
He worked at the London Hospital Medical College from 1980 to ‘97 then joined the PHLS (now PHE), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory.
In 2011 he became Professor of Medical Microbiology at the University of East Anglia, where he remains. He has worked and written extensively on the evolution and epidemiology of antibiotic resistance, has edited for several journals, and serves on the Government’s Antimicrobial Resistance & Healthcare Associated Infection Advisory Committee.
Outside work he walks, including the 3500-mile perimeter of England and Wales.
David Livermore
Professor of Medical Microbiology, University of East Anglia
David Livermore gained his BSc in 1978 and PhD in 1983.
He worked at the London Hospital Medical College from 1980 to ‘97 then joined the PHLS (now PHE), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory.
In 2011 he became Professor of Medical Microbiology at the University of East Anglia, where he remains. He has worked and written extensively on the evolution and epidemiology of antibiotic resistance, has edited for several journals, and serves on the Government’s Antimicrobial Resistance & Healthcare Associated Infection Advisory Committee.
Outside work he walks, including the 3500-mile perimeter of England and Wales.
Dr. Jakko van Ingen
Clinical Microbiologist at the Radboud University Medical Center in Nijmegen, the Netherlands
Published >200 articles in international peer-reviewed medical journals and 10 book chapters on mycobacterial disease.
September 21st, 2009, obtained “cum laude” PhD degree, after successful defense of thesis entitled “Nontuberculous mycobacteria: From gene sequences to clinical relevance”, at the Radboud University Nijmegen, the Netherlands.
Goals: to improve treatment outcome in nontuberculous mycobacterial disease.
Expertise: Mycobacteriology, clinical microbiology, molecular typing
Dr. Jakko van Ingen
Clinical Microbiologist at the Radboud University Medical Center in Nijmegen, the Netherlands
Published >200 articles in international peer-reviewed medical journals and 10 book chapters on mycobacterial disease.
September 21st, 2009, obtained “cum laude” PhD degree, after successful defense of thesis entitled “Nontuberculous mycobacteria: From gene sequences to clinical relevance”, at the Radboud University Nijmegen, the Netherlands.
Goals: to improve treatment outcome in nontuberculous mycobacterial disease.
Expertise: Mycobacteriology, clinical microbiology, molecular typing